Scholars Central

OtherPublished 5 Aug 2010

Regadenoson myocardial perfusion imaging

Authors: Gilbert Zoghbi, Ami E Iskandrian

Imaging in Medicine

Volume 2 · Issue 4 · Pages 395–406

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Vasodilator stress myocardial perfusion imaging accounts for approximately half of the stress studies in the USA. Regadenoson, a selective A2A receptor agonist, was recently approved for clinical use by the US FDA. By contrast, compared with adenosine, regadenoson is administered as a single- and fixed-dose bolus, has comparable hyperemic effect and a better tolerability profile. This article will address and highlight the various regadenoson attributes, properties and the preclinical and clinical studies that have been conducted to date

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Imaging in Medicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImaging in Medicine
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “Gilbert Zoghbi”
  • BylineArticles whose byline prints “Ami E Iskandrian”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels